David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
KB Home
KBH
$3.44B
| $1.06M | ﹤0.01% |
14,907
+1,707
| +13% | +$109K |
|
2927
Heritage Insurance Holdings
HRTG
$1.02B
| $1.06M | ﹤0.01% |
+99,188
| New | +$699K |
|
2928
Emergent Biosolutions
EBS
$306M
| $1.05M | ﹤0.01% |
416,664
-769,888
| -65% | -$1.74M |
|
2929
Brunswick
BC
$5.16B
| $1.05M | ﹤0.01% |
+10,892
| New | +$956K |
|
2930
Cullinan Oncology
CGEM
$1.47B
| $1.05M | ﹤0.01% |
61,621
+12,702
| +26% | +$196K |
|
|
BUJA
2931
DELISTED
Bukit Jalil Global Acquisition 1
BUJA
| $1.05M | ﹤0.01% |
100,000
| – | – |
|
2932
CALL
3D Systems Corp
DDD
$548M
| $1.05M | ﹤0.01% |
236,400
| – | – |
|
|
GOOS
2933
CALL
Canada Goose Holdings
GOOS
$793M
| $1.05M | ﹤0.01% |
86,900
| – | – |
|
2934
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$584M
| $1.04M | ﹤0.01% |
+30,080
| New | +$1.07M |
|
2935
CALL
Camping World
CWH
$672M
| $1.04M | ﹤0.01% |
37,300
-8,800
| -19% | -$227K |
|
2936
Vitamin Cottage Natural Grocers
NGVC
$642M
| $1.04M | ﹤0.01% |
57,358
+4,023
| +8% | +$64.6K |
|
|
SILK
2937
PUT
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.04M | ﹤0.01% |
+56,500
| New | +$897K |
|
|
KALV
2938
DELISTED
KalVista Pharmaceuticals
KALV
| $1.03M | ﹤0.01% |
87,093
-1,670
| -2% | -$22.3K |
|
2939
Tractor Supply
TSCO
$18.2B
| $1.03M | ﹤0.01% |
+19,700
| New | +$942K |
|
2940
Protagonist Therapeutics
PTGX
$9.8B
| $1.03M | ﹤0.01% |
+35,640
| New | +$970K |
|
2941
Kanzhun
BZ
$8.42B
| $1.03M | ﹤0.01% |
+58,726
| New | +$926K |
|
2942
Innospec
IOSP
$2.36B
| $1.03M | ﹤0.01% |
7,977
-2,031
| -20% | -$247K |
|
2943
CALL
Iovance Biotherapeutics
IOVA
$3.66B
| $1.03M | ﹤0.01% |
+69,400
| New | +$808K |
|
2944
Sportradar
SRAD
$3.83B
| $1.03M | ﹤0.01% |
88,359
-9,641
| -10% | -$102K |
|
2945
SiriusPoint
SPNT
$2.79B
| $1.03M | ﹤0.01% |
80,900
| – | – |
|
2946
Riskified
RSKD
$788M
| $1.03M | ﹤0.01% |
189,836
+131,707
| +227% | +$626K |
|
2947
CALL
LyondellBasell Industries
LYB
$20.2B
| $1.02M | ﹤0.01% |
10,000
-240,300
| -96% | -$23.4M |
|
|
LX
2948
LexinFintech Holdings
LX
$194M
| $1.02M | ﹤0.01% |
567,680
-38,809
| -6% | -$71.8K |
|
|
LPRO
2949
DELISTED
Open Lending Corp
LPRO
| $1.02M | ﹤0.01% |
163,115
-152,216
| -48% | -$1.12M |
|
2950
PUT
Titan Machinery
TITN
$438M
| $1.02M | ﹤0.01% |
+41,100
| New | +$1.07M |
|
Similar funds
David Shaw's Q1 2024 Portfolio in Review
As of Q1 2024, David Shaw held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Arm worth $297M.
- David Shaw's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- David Shaw added most to Apple in Q1 2024, an estimated $820M increase.
- David Shaw's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- David Shaw fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- David Shaw's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- David Shaw opened 655 new positions and closed 634 in Q1 2024.
- David Shaw's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.